The Enterprise Value as of November 2024 (TTM) for Bio-Path Holdings, Inc. (BPTH) is -240810.00

According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -240810.00. This represents a change of -111.55% compared to the average of 2.09M of the last 4 quarters.

Bio-Path Holdings, Inc. (BPTH) Historical Enterprise Value (quarterly & annually)

How has BPTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Bio-Path Holdings, Inc. over the last ten years is 991.51M. The current -240810.00 Enterprise Value has changed -102.43% with respect to the historical average. Over the past ten years (40 quarters), BPTH's Enterprise Value was at its highest in in the December 2014 quarter at 4.74B. The Enterprise Value was at its lowest in in the June 2024 quarter at -823720.00.

Bio-Path Holdings, Inc. (BPTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bio-Path Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Path Holdings, Inc. (BPTH) Average Enterprise Value

How has BPTH Enterprise Value performed in the past?

The current Enterprise Value of Bio-Path Holdings, Inc. (BPTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bio-Path Holdings, Inc. (BPTH) Enterprise Value vs. Peers

How is BPTH’s Enterprise Value compared to its peers?

Bio-Path Holdings, Inc.’s Enterprise Value is less than Catalyst Biosciences, Inc. (19.42M), greater than Diffusion Pharmaceuticals Inc. (-1447403.00), less than Capricor Therapeutics, Inc. (847.41M), less than NextCure, Inc. (22.24M), greater than Pulmatrix, Inc. (-6142714.00), greater than Bellerophon Therapeutics, Inc. (-3941626.00), less than Crinetics Pharmaceuticals, Inc. (4.89B), greater than Applied Molecular Transport Inc. (-5743713.00), less than Aileron Therapeutics, Inc. (64.72M), less than Benitec Biopharma Inc. (162.42M), less than Onconova Therapeutics, Inc. (4.51M), greater than Moleculin Biotech, Inc. (-3315456.00), less than Achieve Life Sciences, Inc. (166.35M), less than Icosavax, Inc. (713.87M), less than Akari Therapeutics, Plc (25.73M),

Build a custom stock screener for Bio-Path Holdings, Inc. (BPTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Path Holdings, Inc. (BPTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.